Drug Maker Merck Pulls Vioxx One of the world's largest drug makers, Merck & Co., announces that it is taking its arthritis drug Vioxx off the market. A study found patients taking high doses of Vioxx had more than three times the risk of heart attack or sudden cardiac death. Hear NPR's Richard Knox.
NPR logo

Merck to Pull Vioxx Off Market over Heart Risks

  • Download
  • <iframe src="https://www.npr.org/player/embed/4054810/4054811" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
Merck to Pull Vioxx Off Market over Heart Risks

Merck to Pull Vioxx Off Market over Heart Risks

Merck to Pull Vioxx Off Market over Heart Risks

  • Download
  • <iframe src="https://www.npr.org/player/embed/4054810/4054811" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">

One of the world's largest drug makers, Merck & Co., announces that it is taking its arthritis drug Vioxx off the market. A study found patients taking high doses of Vioxx had more than three times the risk of heart attack or sudden cardiac death. Hear NPR's Richard Knox.